Catalyst Wire Dossier Catalyst Wire Dossier

Nalrexone

nalrexone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nalrexone, covering 2017-09-06 to 2017-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Nalrexone Facilitated Discontinuation of Buprenorphine [Phase 1, Phase 2]

See pricing